Bausch + Lomb announced the U.S. launch of Zenlens Echo, a non-prosthetic custom scleral contact lens technology designed for a range of fit needs, including patients with advanced ocular conditions such as corneal degeneration.
“Fitting patients who have advanced ocular conditions can be extremely complex,” Jason Jedlicka, OD, associate professor and director of the Cornea and
/PRNewswire/ Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to.
Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium
News provided by
Share this article
Share this article
Bausch + Lomb Will Also Host Presentation on Technologies that Can Help Create Efficiencies in Fitting Zenlens™ Scleral Lenses on Patients
LAVAL, QC, Jan. 20, 2021 /PRNewswire/ Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ( Bausch Health ), today announced that two poster presentations will feature data on the new Bausch + Lomb INFUSE™ silicone hydrogel (SiHy) daily disposable contact lenses during the virtual Global Specialty Lens Symposium (GSLS) Annual Meeting, which takes place Jan. 21-23, 2021. Bausch + Lomb also will offer attendees the opportunity to participate in a presentation about its Zenlens™ scleral lenses.